The NHS, Blood, and VAT: Why Species Matters

VAT and blood and human tissue

The UK provides VAT exemptions for supplies of human blood, organs, and tissues used for medical purposes. This makes perfect sense – the NHS shouldn’t be paying tax on life-saving blood transfusions or organ transplants. When hospitals receive human blood products or therapeutic substances derived from blood, they’re exempt from VAT.

Human organs are rarely supplied as business transactions anyway, since it’s illegal to sell organs for transplantation in the UK. When they are supplied for medical research or therapeutic purposes, they fall under this exemption.

Not all blood is created equal

Here’s where things get interesting. The exemption only applies to human blood and blood products. If you’re dealing with animal blood or animal-derived products, you’re back to standard rate VAT at 20%.

Think about that for a moment. A hospital receiving human blood for transfusion? VAT exempt. A research facility receiving animal blood for the exact same type of medical research? Standard rated at 20%.

The guidance is quite specific: products must be derived from human blood and intended for therapeutic purposes to qualify. Even genetically engineered products that use human blood as a carrier but have a synthetic active ingredient don’t make the cut – they’re standard rated.

Why does this distinction exist?

The reasoning behind this is actually fairly straightforward, even if the outcome seems odd. The VAT exemption exists specifically to reduce the cost burden on healthcare services dealing with human biological materials for medical treatment.

Human blood donation and transfusion represent a unique healthcare ecosystem. Blood is donated freely by volunteers, processed by blood services, and used directly in patient care. The exemption recognises the public health importance of keeping these services affordable and accessible.

Animal blood, on the other hand, is typically obtained through commercial veterinary or research channels. It’s used in laboratories, research facilities, and sometimes in veterinary medicine – contexts that don’t carry the same policy imperative for VAT relief.

The practical implications

For organisations working in medical research or veterinary science, this creates some interesting accounting scenarios. A research lab conducting comparative studies might purchase both human blood samples (exempt) and animal blood samples (standard rated) for the same project.

Similarly, facilities that use animal-derived blood products for medical or research purposes must account for VAT at the standard rate, even though the work itself may ultimately benefit human medicine.

The distinction also extends to blood-derived products. Human plasma? Exempt. Animal serum? Standard rated. It’s the biological source that determines the tax treatment, not the scientific application or the therapeutic benefit.

What this tells us about VAT

This human versus animal blood distinction is a perfect example of how detailed and specific VAT legislation needs to be. The tax authority can’t just write ‘medical supplies are exempt’ and leave it at that. They need to define exactly what counts, under what circumstances, and from what sources.

The result is guidance that sometimes seems almost absurdly specific. But there’s a logic to it. Every boundary that gets drawn – human versus animal, therapeutic versus research, blood versus tissue – exists because at some point, someone asked the question and HMRC needed to provide an answer.

These distinctions also reveal the policy priorities embedded in tax law. The exemption for human blood and tissue reflects a clear decision that direct healthcare should be shielded from VAT. The standard rating of animal blood shows where that policy boundary ends.

It’s oddly fascinating when you think about it. Two vials of blood sitting on a laboratory shelf. One from a human donor, one from an animal. Scientifically, they might be used for nearly identical purposes. But for VAT purposes, they exist in completely different categories.

And somewhere in HMRC, there’s a tax officer who had to write these exact distinctions into official guidance, knowing that one day, someone would need to know the answer.